ITOC

iTonic Holdings Ltd.

$2.01

8.65%
SectorHealthcareIndustryMedical DevicesCountryChina

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Source: Yahoo Finance
Q-Score35/ 100
Market Cap$14.7M
P/E—
Dividend Yield0.06%
52-Week Range—
Next Earnings—
Analysts—
Beta0.75
AI summary

Price & performance

1M-34.2%
3M-27.6%
YTD-56.8%
1Y-69.4%
52-week range—
Beta0.75
Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk28
Performance51
Valuation30
Profitability24
Leverage66
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$523K+16.7%
Net income-$5.1M
Net margin-974.7%-827.3 pts
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtMar 30, 2026
Material weakness in controlsMar 30, 2026
Filings, findings and the timeline

Revenue exposure

Largest customer26%
Regions, segments, customers and suppliers

Valuation

ITOCIndustryP/E—29.61P/S28.113.49EV/EBITDA—18.38P/B2.403.39PEG——
Dividend yield0.06%
Every valuation metric